Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Compliance with BAY86-5300 Flexible Extended Regimen
NCT01257984Phase 3Completed
- Sponsor
- Bayer
- Start
- Dec 2010
- Primary completion
- Aug 2012
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 3 trial of ethinyl estradiol + drospirenone in contraception, sponsored by Bayer. Started Dec 2010; status: completed.
02
Drugs
ethinyl estradiol + drospirenone
03
Conditions
contraception
Beyond the preview
Go deeper on NCT01257984.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01257984.